Clinical Trial Update: Vaccination of Triple Negative Breast Cancer Patients [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update reporting completed Phase 1/Phase 2 results for a vaccination approach in patients with triple-negative breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Triple-negative Breast Cancer

Snippet

Sponsor: University of Arkansas | Conditions: Triple Negative Breast Cancer, Breast Neoplasms | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2024-07-05